Liminatus Pharma Plunges 12.36% Amid Volatility Pause

On June 13, 2025, Liminatus Pharma experienced a significant drop of 12.36% in pre-market trading, marking a notable decline in its stock performance.

Liminatus Pharma's trading was temporarily halted due to a volatility trading pause. This action was taken to manage excessive market fluctuations, which can occur during periods of high volatility. The halt was implemented to stabilize the market and prevent further drastic price movements.

Liminatus Pharma's stock has been subject to significant volatility, which has led to temporary trading halts. These halts are designed to curb excessive price movements and provide a period of stability for the market. Such actions are common during times of high market uncertainty and are aimed at protecting investors from sudden and dramatic price changes.